|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
$23.50 Stock. 
Buyout looming. Enjoy.
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
5-Feb-10 07:27 am |
| |
| 2. |
I&&39;m confused with this stock
The swings, despite insider trading, and solid phase
III data. It's such an important medical need
and large pharma have not invested in antibiotics
in the last 10...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
21-Jan-10 08:50 am |
| |
| 3. |
Keep your shares....
This thing will move way up - big pharma are in need
of drugs higher up in the development chain.....this
is a $25 price tag attached to this one. Good luck
and let's see in 3...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
16-Oct-09 09:55 am |
| |
| 4. |
Re: Technicals
yes technicals look sharp indeed. However, I think
large pharma is looking into this company.
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
14-Oct-09 02:14 pm |
| |
| 5. |
Interesting...
BY JULIA MENGEWEIN ZURICH—Swiss pharmaceutical company
Novartis AG said Thursday it has gained exclusive
world-wide rights to market a drug candidate that
is currently in late-stage...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
8-Oct-09 04:24 pm |
| |
| 6. |
Novartis getting into antibiotics....
Very interesting for OPTR --- large pharma have negleted
this field. Interest will re-emerge....go optr.
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
8-Oct-09 08:49 am |
| |
| 7. |
Re: Going down to $20....
No - sorry. You are not in the business and there is
NO WAY, MDs will start putting patients on this drug
for breast unless phase III are quite successful in
survival rates.... Three...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Onyx Pharmaceuticals Inc. (ONXX)
|
|
francolaval |
|
1-Oct-09 10:12 am |
| |
| 8. |
Re: Going down to $20....
phase II data, when positive, is not a method to get
MDs to prescribe drug - not in oncology. Sorry - you
got it wrong. Secondly, success of phase II study,
does not guarantee success of phase III - i.e. th
e...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Onyx Pharmaceuticals Inc. (ONXX)
|
|
francolaval |
|
1-Oct-09 09:49 am |
| |
| 9. |
Mgmt of C-difficile top priority for hospitals
This will be a revenu-based pharma with niche pipeline
- envy of other pharma. OPTR is well-packaged and
ready for some talks with large pharma. Well priced,
good product, large potential...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Optimer Pharmaceuticals, Inc. (OPTR)
|
|
francolaval |
|
1-Oct-09 08:13 am |
| |
| 10. |
Going down to $20....
Over hype..there is less than 50/50 chance that this
will work in phase III breast.... Liver/Kidney - that's
all for Onxx.Nex
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Onyx Pharmaceuticals Inc. (ONXX)
|
|
francolaval |
|
30-Sep-09 11:56 am |
| |
| 11. |
For when the bid for BAYER?
It would be an exceptional combination....they will
only have to spin off their material sciences to DOW
or BASF
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
francolaval |
|
8-May-09 07:57 am |
| |
| 12. |
NVS acquiring Bayer?
Any comments on this rumour ?-
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
francolaval |
|
7-Apr-09 08:46 am |
| |
| 13. |
NVS buying Bayer....
ANY COMMENTS
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
francolaval |
|
27-Jan-09 07:22 pm |
| |
| 14. |
FDA - NSF and Vasovist
Looking at what the FDA has asked the contrast makers,
epix will have no choice but to do a study in renally
impaired patients within 2 years of approval. Can
...
Business & Finance > Investments > Stocks (A to Z) > Stocks E >
EPIX Pharmaceuticals, Inc.
|
|
francolaval |
|
12-Nov-08 08:16 am |
| |
| 15. |
Re: CC Today
Sold. They are cooked. Massively in debt. Delisting.
Cash until Q1 2009....they will need to do additional
clinical trial with VV - as per the other vendors
- as this is a FDA...
Business & Finance > Investments > Stocks (A to Z) > Stocks E >
EPIX Pharmaceuticals, Inc.
|
|
francolaval |
|
4-Nov-08 10:53 am |
| |
| 16. |
NVS and BAY??
Bayer is NVS's next target....
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
francolaval |
|
31-Oct-08 09:53 am |
| |
| 17. |
Will Novartis take-over Bayer?
Bayer has Animal, crop, pharma,....pipeline....
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Novartis AG (NVS)
|
|
francolaval |
|
19-Sep-08 08:50 am |
| |
| 18. |
Re: PFE seems inexpensive
Pfizer will "Lehman Brother-itself if it does
not acquire a pipeline.....it may not happen overnight
but will happen within 2 yrs.
Business & Finance > Investments > Stocks (A to Z) > Stocks P >
Pfizer Inc. (PFE)
|
|
francolaval |
|
16-Sep-08 08:21 am |
| |